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Purpose or Objective: Effective treatment options are 
needed for locally advanced lung cancer. Increased 
treatment precision and decreased treatment volumes are 
mandatory for more aggressive radiotherapy. Adaptive 
radiotherapy (ART) was implemented to adjust the treatment 
plan to positional or volumetric changes of the tumour, and 
to normal tissue changes like atelectasis. Recently, ART was 
shown to improve local control without increasing radiation 
pneumonitis [1]. The present study investigates the 
dosimetric consequences of ART for 235 patients. 
 
Material and Methods: ART intervention rules were 
implemented for lung cancer patients treated with definitive 
chemo-radiotherapy, in concordance with smaller PTV 
margins and daily online soft-tissue matching. Intervention 
rules derived from geometrical criteria for normal tissue and 
tumour changes. Violation of these for three consecutive 
fractions triggered an evaluation. If the observed change was 
suspected to lead to an underdosage of tumour/lymph nodes 
or an overdosage of normal tissue, a CT rescan and a replan 
were made. The original plan was recalculated on the rescan 
to evaluate the consequence of replanning for patients 
receiving a plan adaptation in a cohort of 235 consecutive 
patients treated with ART. For the first 50 patients, in order 
to assess the efficacy of the intervention rules, two 
additional surveillance CT scans were acquired during the RT 
course and the treatment plans were recalculated on these 
scans. The change in lung dose due to the implementation of 
ART was found comparing the treatment plans of the first 50 
ART-patients with 50 pre-ART-patients. 
 
Results: Due to ART, the PTV decreased from 569 cm3 to 398 
cm3, and consequentially the mean lung dose decreased from 
14.1 Gy (SE 0.6) to 12.6 (SE 0.6) Gy. The criterion for the 
need of adaptation was a decrease in target coverage of 
CTV>1% or PTV>3%. The cohort of patients with two 
surveillance scans showed coverage above this in 94% of the 
cases not replanned. Sixty-one (26%) patients treated with 
ART had at least one replan. In total 77 adaptations were 
made. Fifty three adaptations corrected for a decrease in 
overall target coverage. Figure 1 shows the extent of 
decrease and designates the reason for replanning. In five 
patients with several separate targets under dosage of one of 
the targets were seen. One patient was replanned in order to 
avoid overdosage of spinal cord. Three patients were 
replanned due to changes in atelectasis making match 
evaluation impossible. In 15 patients, target shrinkage or less 
conformal dose distributions counterbalanced the geometric 
shifts that triggered adaptation. 
 
 
Conclusion: The implementation of soft-tissue match and 
ART secured high treatment precision and allowed safe 
margin reduction in terms of persistent target coverage. The 
reduced margins reduced the mean dose to the lung.  
[1] M Tvilum et al. Acta Oncol 2015, Acta Oncol. 2015 Jul 
24:1-8. 
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Purpose or Objective: In rectal cancer 15% of the patients 
show a pathological complete response (pCR) after neo-
adjuvant chemo-radiotherapy and these patients show better 
overall survival. To increase this pCR rate, in several studies 
a boost dose is given to the tumor. To safely deliver this 
boost, insight in the tumor position is needed. Currently, 
online imaging techniques provide no contrast of the tumor. 
However, since tumors are situated in the rectal wall, which 
is visible on online imaging like CBCT, the rectal wall position 
may be used as a surrogate for the tumor position. We 
therefore investigate the feasibility of tracking a part of the 
rectal wall close to the initial tumor as a motion surrogate 
for the tumor, to be used in online adaptive boost 
radiotherapy in rectal cancer. 
 
Material and Methods: We scanned 16 patients daily on a 
1.5T MRI scanner during a one-week short course of 
radiotherapy (5 times 5Gy). Rectum and tumor were 
delineated on the T2 weighted scan of each day. All scans 
were registered on bony anatomy, mimicking daily patient 
set-up. For both tumor and rectum separately, displacements 
from the first day to every other day were determined, by 
calculating per voxel the shortest distance to each 
delineation. 
To find out how proximate to the tumor we have to define 
our rectum motion surrogate, we selected that part of the 
rectum that lies within 1, 3, 5, 7 and 10 mm of the initial 
tumor (ProximateRectum). For each point on these 
ProximateRectums, we determined the nearest point of the 
tumor as corresponding point. Between all the corresponding 
points of ProximateRectum and tumor, the displacements to 
every day were correlated to each other. We also determined 
how much of the variance in tumor motion was explained by 
each ProximateRectum. These analysis were done for the 1, 
3, 5, 7 and 10 mm ProximateRectum separately. 
 
Results: Different motion patterns were found for tumor and 
ProximateRectums, especially when movement of the tumor 
is in cranial caudal direction, since no anatomical landmarks 
are available (see figure 1). We found correlations of ρ = 
0.66, 0.64, 0.55, 0.53 and 0.45 (all p≤ 0.001) for 
ProximateRectum of respectively 1, 3, 5, 7 and 10 mm. This 
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results in only 44%, 40%, 31%, 28% and 20% of the variance of 
tumor motion being explained by local rectum motion for 
respectively ProximateRectums of 1, 3, 5, 7 and 10 mm. 
 
Conclusion: Even when the rectal motion surrogate is 
defined within 1 mm of the tumor, tracking this part of the 
rectal wall will not result in an accurate tumor positions 
since only 44% of the variance in tumor motion is explained 
by tracking the rectal wall. The lack of anatomical landmarks 
prevents finding the true rectum deformation and thus an 
accurate tumor position. Especially for motion in cranial-
caudal direction, there is poor correlation between tumor 
and local rectal motion. Therefore, anatomical landmarks are 
needed for positioning the tumor e.g. direct imaging of the 
tumor using MRI or indirect imaging of the tumor using 
implanted markers. 
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Purpose or Objective: In cervical cancer, adaptive radiation 
therapy (ART) can be applied to compensate for interfraction 
target motion. However, organs at risk (OAR) still receive 
substantial dose when photon-based ART is applied. Adaptive 
proton therapy (APT) holds the promise to further limit OAR 
dose while maintaining adequate target coverage. Our aim 
was to investigate the potential dosimetric advantages of 
image-guided APT (IGAPT) compared with photon-based 
image-guided ART (IGART). 
 
Material and Methods: Twelve cervical cancer patients 
treated with photon therapy were included in this 
retrospective study. Besides the clinically acquired full 
bladder planning CT, additional empty bladder planning CT 
and weekly repeat CTs were acquired for study purposes. 
Planning CTs were registered based on bony anatomy and 
multiple interpolated cervix-uterus structures were derived 
using a point-based non-rigid registration method. For each 
interpolated structure, a photon (VMAT) and a proton (IMPT) 
plan was created to build patient-specific plan libraries. All 
plans were robustly optimized with a prescribed physical CTV 
dose of 46 Gy-equivalent (GyE) (23 x 2 GyE) for pelvic 
irradiation or 50.4 GyE (28 x 1.8 GyE) for para-aortic 
irradiation. For each patient, repeat CTs were registered to 
the full bladder planning CT based on bony anatomy and 
IGART and IGAPT treatments were simulated by selecting 
library plans and recalculating the dose. For each simulated 
fraction, CTV coverage (V95% > 98%) was assessed and 
differences in Dmean and D2cc fraction dose and fractionated 
substitutes of V15Gy, V30Gy and V45Gy parameters (i.e. dose 
levels divided by the number of fractions) for bladder, bowel 
and rectum were evaluated and tested for significance 
(Wilcoxon signed-rank test). Also, fraction dose distributions 
were accumulated and differences in the overall rectum 
toxicity related DVH parameter (V30Gy) and normal tissue 
complication probability (NTCP) for grade 2 acute 
gastrointestinal toxicity were determined. 
 
Results: In 6 fractions (10.7%), the cervix-uterus structure 
deviated substantially from the pre-treatment derived 
structures. Adequate CTV coverage was obtained in 92% (96%) 
of the remaining fractions for IGAPT (IGART) which resulted 
in adequate CTV coverage on average per patient. All DVH 
parameters for bladder, bowel and rectum, except for the 
fractionated substitute of rectum V45Gy, were improved 
using IGAPT (Figure). Also, the mean dose to bowel, bladder 
and rectum was reduced significantly (p<0.01). Compared to 
IGART, IGAPT indicated a mean reduction of 7% for rectum 
V30Gy and a mean decrease from 0.33 to 0.18 in bowel 
NTCP. 
 
 
 
Conclusion: This study demonstrates the feasibility of IGAPT 
in cervical cancer using a plan library based adaptive strategy 
to compensate for interfraction target motion. Compared to 
photon-based IGART, IGAPT maintains adequate target 
coverage while a significant dose reduction in bladder, bowel 
and rectum can be achieved. 
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